Efficacy of Ketorolac 0.4% in Prostaglandin Suppression

NCT00791323 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Ketorolac 0.4%
DRUG: Lubricating Eye Drop

Sponsor

Allergan